Advocacy at a Glance 1/8/21 Advocacy at a Glance 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More Analysis and Commentary 12/5/20 Analysis and Commentary 12/5/20 CDRH Update and Future Priorities Read More Advocacy at a Glance 12/5/20 Advocacy at a Glance 12/5/20 CDRH Director Presents at Alliance Webinar Read More Advocacy at a Glance 11/8/20 Advocacy at a Glance 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More Advocacy at a Glance 10/31/20 Advocacy at a Glance 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More Advocacy at a Glance 11/30/18 Advocacy at a Glance 11/30/18 A Full Year Continuing Resolution: The Biggest Threat to FDA’s FY19 Funding Read More Advocacy at a Glance 3/16/18 Advocacy at a Glance 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More Analysis and Commentary 3/11/18 Analysis and Commentary 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More Advocacy at a Glance 3/11/18 Advocacy at a Glance 3/11/18 FDA’s Breakthrough Device Program Featured and more Read More Advocacy at a Glance 9/9/16 Advocacy at a Glance 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More Advocacy at a Glance 10/23/15 Advocacy at a Glance 10/23/15 FDA’s Center for Devices and Radiological Health Updates Regulatory Science Agenda and more Read More
Advocacy at a Glance 1/8/21 Advocacy at a Glance 1/8/21 FDA’s share of the appropriations and stimulus bill are described, with a link for more detail. Read More
Analysis and Commentary 12/5/20 Analysis and Commentary 12/5/20 CDRH Update and Future Priorities Read More
Advocacy at a Glance 12/5/20 Advocacy at a Glance 12/5/20 CDRH Director Presents at Alliance Webinar Read More
Advocacy at a Glance 11/8/20 Advocacy at a Glance 11/8/20 Alliance Webinar with CDRH Director Dr. Jeffrey Shuren Announced Read More
Advocacy at a Glance 10/31/20 Advocacy at a Glance 10/31/20 Pandemic-Related Aid and Delayed Appropriations: to Be Resolved Together in Lame Duck? Read More
Analysis and Commentary 2/7/20 Analysis and Commentary 2/7/20 Shuren Fills Alliance in on Fast-Moving Science and CDRH Needs Read More
Advocacy at a Glance 11/30/18 Advocacy at a Glance 11/30/18 A Full Year Continuing Resolution: The Biggest Threat to FDA’s FY19 Funding Read More
Advocacy at a Glance 3/16/18 Advocacy at a Glance 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More
Analysis and Commentary 3/11/18 Analysis and Commentary 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More
Advocacy at a Glance 3/11/18 Advocacy at a Glance 3/11/18 FDA’s Breakthrough Device Program Featured and more Read More
Advocacy at a Glance 9/9/16 Advocacy at a Glance 9/9/16 CDRH Director Shuren’s Presentation Well Received. Read More
Advocacy at a Glance 10/23/15 Advocacy at a Glance 10/23/15 FDA’s Center for Devices and Radiological Health Updates Regulatory Science Agenda and more Read More
